IMMU - Immunomedics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $98.85. This is a potential upside of $10.99 (12.51%) from yesterday's end of day stock price of $87.86.

Immunomedics's activity chart (see below) currently has 86 price targets and 72 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 95.83% with an average time for these price targets to be met of 216.08 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Sep-2020

$55

5 years 6 months 19 days ago
(15-Sep-2020)

5/5 (100%)

$11.69 (26.99%)

126

Hold Since 14-Sep-2020

$55

5 years 6 months 20 days ago
(14-Sep-2020)

5/5 (100%)

$14.37 (35.37%)

185

Hold Since 14-Sep-2020

$56

5 years 6 months 20 days ago
(14-Sep-2020)

9/9 (100%)

$14.84 (36.05%)

173

$40

$-47.86 (-54.47%)

$19

5 years 7 months 24 days ago
(10-Aug-2020)

5/5 (100%)

$-0.92 (-2.25%)

335

Buy Since 26-May-2017

$55

$-32.86 (-37.40%)

$45

5 years 7 months 28 days ago
(06-Aug-2020)

7/7 (100%)

$11.82 (27.37%)

115

Show more analysts

Please expand the browser size to see the chart

What is IMMU (Immunomedics) average time for price targets to be met?

On average it took 216.08 days on average for the stock forecasts to be realized with a an average price target met ratio 95.83

Which analyst has the current highest performing score on IMMU (Immunomedics) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on IMMU (Immunomedics)?

Madhu Kumar has 8 price targets and 7 ratings on IMMU

Which analyst is the currently most bullish on IMMU (Immunomedics)?

Raghuram Selvaraju with highest potential upside - $0

Which analyst is the currently most reserved on IMMU (Immunomedics)?

Matthew Andrews with lowest potential downside - -$65.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?